Which has the lower trailing P/E, HAS or MEDP?

HAS has the lower trailing P/E: HAS trades at 16.30 and MEDP at 34.53. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HAS or MEDP?

Over the past five years, MEDP grew revenue faster — HAS at a -3.48% CAGR versus MEDP at 22.03%.

Does HAS or MEDP pay a bigger dividend?

HAS pays a dividend (3.09% yield), while MEDP has no payments in the available dividend history.

Is HAS or MEDP more profitable?

MEDP runs the higher net margin — HAS at 15.99% versus MEDP at 17.67%.

How have HAS and MEDP total returns compared?

Over the past 5 years, HAS delivered 4.58% and MEDP delivered 28.06% annualized total return. Past performance doesn't predict future results.

Hasbro, Inc. (HAS) vs Medpace Holdings, Inc. (MEDP)

A side-by-side comparison of Hasbro, Inc. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

Different business models: HAS is classified in Consumer Cyclical; MEDP is classified in Healthcare. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

HAS

Hasbro, Inc.

$13.63B

$96.34Consumer CyclicalDelayed quote: Jul 28, 2026, 4:00 PM EDT

MEDP

Medpace Holdings, Inc.

$15.94B

$570.97HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

Total return — HAS vs MEDP

growth of $100 · dividends reinvested · last 10y

HAS +53.8%MEDP +2020.8%MEDP compounded faster

Log scale — wide-divergence pair

HAS MEDP

HAS vs MEDP: by the numbers

•MEDP is the larger company ($15.94B vs $13.63B market cap).
•HAS trades at the lower trailing earnings multiple (16.30 vs 34.53 P/E), one valuation lens rather than an overall verdict.
•MEDP converts more revenue to profit (17.67% vs 15.99% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs -3.48% CAGR).
•HAS pays a dividend (3.09% yield), while MEDP has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	HAS	MEDP
P/E ratio	16.30	34.53
Forward P/E	14.83	33.60
P/S ratio	2.61	6.09
P/B ratio	17.77	39.07
PEG ratio	0.20	1.82
EV / EBITDA	11.99	27.73
FCF yield	9.35%	4.51%

Profitability

Metric	HAS	MEDP
Gross margin	70.28%	28.76%
Operating margin	23.86%	20.97%
Net margin	15.99%	17.67%
ROE	108.89%	113.29%
ROIC	25.14%	67.94%

Dividends

Metric	HAS	MEDP
Dividend yield	3.09%	N/A

Growth (annualized)

Metric	HAS	MEDP
Revenue CAGR (5Y)	-3.48%	22.03%
EPS CAGR (5Y)	N/A	30.90%
FCF CAGR (5Y)	-0.49%	24.42%
Total return CAGR (5Y)	1.77%	28.06%

Frequently asked

Which has the lower trailing P/E, HAS or MEDP?: HAS has the lower trailing P/E: HAS trades at 16.30 and MEDP at 34.53. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HAS or MEDP?: Over the past five years, MEDP grew revenue faster — HAS at a -3.48% CAGR versus MEDP at 22.03%.
Does HAS or MEDP pay a bigger dividend?: HAS pays a dividend (3.09% yield), while MEDP has no payments in the available dividend history.
Is HAS or MEDP more profitable?: MEDP runs the higher net margin — HAS at 15.99% versus MEDP at 17.67%.
How have HAS and MEDP total returns compared?: Over the past 5 years, HAS delivered 4.58% and MEDP delivered 28.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HAS analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Hasbro P/E ratio Medpace P/E ratio Hasbro dividend yield Medpace dividend yield Hasbro ROE Medpace ROE Hasbro operating margin Medpace operating margin Hasbro revenue growth Medpace revenue growth Hasbro free cash flow Medpace free cash flow

Hasbro & Medpace appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.